E-cadherin Inactivation in Lobular Carcinoma in Situ of the Breast
Author Information
Author(s): CBJ Vos, AM Cleton-Jansen, G Berx, WJF de Leeuw, NT ter Haar, F van Roy, CJ Cornelisse, JL Peterse, MJ van de Vijver
Primary Institution: Leiden University Medical Centre
Hypothesis
E-cadherin inactivation plays a crucial role in the development of lobular breast carcinoma.
Conclusion
E-cadherin is inactivated in lobular carcinoma in situ, indicating it is an early event in breast cancer development.
Supporting Evidence
- E-cadherin expression was absent in all six cases of lobular carcinoma in situ.
- All 150 cases of ductal carcinoma in situ showed clear E-cadherin expression.
- Identical mutations and loss of heterozygosity were found in both lobular carcinoma in situ and adjacent invasive lobular carcinoma.
Takeaway
This study found that a protein called E-cadherin is missing in certain early forms of breast cancer, which might help us understand how these cancers start.
Methodology
The study analyzed E-cadherin expression and mutations in 156 cases of in situ carcinoma, including 150 ductal carcinoma in situ and 6 lobular carcinoma in situ.
Want to read the original?
Access the complete publication on the publisher's website